{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:29:08Z","timestamp":1778272148683,"version":"3.51.4"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.2169\/internalmedicine.1515-22","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T22:12:25Z","timestamp":1684879945000},"page":"101-106","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis B Virus-related Membranous Nephropathy with Crescentic Formation in an Inactive Carrier of Positive Hepatitis B Surface Antigen with Undetectable DNA under Anti-viral Treatment"],"prefix":"10.2169","volume":"63","author":[{"given":"Noriyuki","family":"Kounoue","sequence":"first","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"},{"name":"Department of Nephrology, Toho University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Oguchi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetuo","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Yamaguchi&apos;s Pathology Laboratory, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hashiguchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keio University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenari","family":"Nagai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Hisamatsu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Toho University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Amarapurkar DN, Amarapurkar AD. Extrahepatic manifestations of viral hepatitis. Ann Hepatol 1: 192-195, 2002.","DOI":"10.1016\/S1665-2681(19)32165-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bhimma R, Coovadia HM. Hepatitis B Virus-associated nephropathy. Am J Nephrol 24: 198-211, 2004.","DOI":"10.1159\/000077065"},{"key":"3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(71)92572-4","volume":"2","author":"B Combes","year":"1971","unstructured":"3. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2: 234-237, 1971.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Lin CY. Hepatitis B virus-associated membraneous nephropathy: clinical features, immunological profiles and outcome. Nephron 55: 37-44, 1990.","DOI":"10.1159\/000185916"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M. Free &quot;small&quot; and IgG-associated &quot;large&quot; hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 300: 814-819, 1979.","DOI":"10.1056\/NEJM197904123001502"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Liaw YF. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 3: 425-433, 2009.","DOI":"10.1007\/s12072-009-9140-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sethi S, Madden BJ, Debiec H, et al. Exostosin 1\/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30: 1123-1136, 2019.","DOI":"10.1681\/ASN.2018080852"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97: 163-174, 2020.","DOI":"10.1016\/j.kint.2019.09.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 26: 709-715, 2013.","DOI":"10.1038\/modpathol.2012.207"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Xie Q, Li Y, Xue J, et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 41: 345-353, 2015.","DOI":"10.1159\/000431331"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009.","DOI":"10.1056\/NEJMoa0810457"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wang R, Wu Y, Zheng B, et al. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. Sci Rep 11: 18407, 2021.","DOI":"10.1038\/s41598-021-98010-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li D, Gao G, Jiang H, Tang Z, Yu Y, Zang G. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients. Eur J Gastroenterol Hepatol 27: 65-69, 2015.","DOI":"10.1097\/MEG.0000000000000236"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Li PK, Lai FM, Ho SS, Wong KC, Lui SF, Lai KN. Acute renal failure in hepatitis B virus-related membranous nephropathy with mesangiocapillary transition and crescentic transformation. Am J Kidney Dis 19: 76-80, 1992.","DOI":"10.1016\/S0272-6386(12)70207-X"},{"key":"15","unstructured":"15. Taskapan H, Oymak O, Dogukan A, Ozbakir O, Utas C. Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 54: 161-163, 2000."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(70)90339-9","volume":"2","author":"DJ Gocke","year":"1970","unstructured":"17. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 2: 1149-1153, 1970.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yang Y, Ma YP, Chen DP, Zhuo L, Li WG. A meta-analysis of antiviral therapy for hepatitis B virus-associated membranous nephropathy. PLoS One 11: e0160437, 2016.","DOI":"10.1371\/journal.pone.0160437"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ochi A, Ishimura E, Ichii M, et al. Successful treatment of hepatitis B virus-associated membranous nephropathy with entecavir and immunosuppressive agents. Nephrology (Carlton) 19: 595-596, 2014.","DOI":"10.1111\/nep.12292"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhang Y, Chen S, Yang D, et al. Efficacy and safety of long-term corticosteroid monotherapy in 26 cases of nephrotic syndrome with biopsy-proven membranous nephropathy induced by seronegative hepatitis B virus-associated glomerulonephritis. Nephron 145: 113-122, 2021.","DOI":"10.1159\/000511467"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/1\/63_1515-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:30:06Z","timestamp":1715574606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/1\/63_1515-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1515-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"1515-22"}}